BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25032514)

  • 21. Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells.
    Chen LJ; Ye H; Zhang Q; Li FZ; Song LJ; Yang J; Mu Q; Rao SS; Cai PC; Xiang F; Zhang JC; Su Y; Xin JB; Ma WL
    Toxicol Appl Pharmacol; 2015 Mar; 283(2):75-82. PubMed ID: 25595642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
    Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
    Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway.
    Kim KH; Lee S; Lee H; Shin D; Min D; Kim M; Ryu B; Kim HW; Bae H
    Sci Rep; 2018 Nov; 8(1):16860. PubMed ID: 30443024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
    Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
    Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
    Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplified canonical transforming growth factor-β signalling
    Sibinska Z; Tian X; Korfei M; Kojonazarov B; Kolb JS; Klepetko W; Kosanovic D; Wygrecka M; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Guenther A; Schermuly RT
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28182573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardin Is Involved in Mesothelial-Mesenchymal Transition of Human Pleural Mesothelial Cells.
    Tucker T; Tsukasaki Y; Sakai T; Mitsuhashi S; Komatsu S; Jeffers A; Idell S; Ikebe M
    Am J Respir Cell Mol Biol; 2019 Jul; 61(1):86-96. PubMed ID: 30605348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.
    Li X; Ma L; Huang K; Wei Y; Long S; Liu Q; Zhang D; Wu S; Wang W; Yang G; Zhou H; Yang C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
    Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1-induced Pulmonary Fibrosis.
    Bellaye PS; Shimbori C; Upagupta C; Sato S; Shi W; Gauldie J; Ask K; Kolb M
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):461-470. PubMed ID: 29115860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of 150-kDa oxygen-regulated protein (ORP150) stimulates bleomycin-induced pulmonary fibrosis and dysfunction in mice.
    Tanaka K; Shirai A; Ito Y; Namba T; Tahara K; Yamakawa N; Mizushima T
    Biochem Biophys Res Commun; 2012 Sep; 425(4):818-24. PubMed ID: 22892132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC1 intracellular bioactivation mediates lung fibrosis.
    Milara J; Ballester B; Montero P; Escriva J; Artigues E; Alós M; Pastor-Clerigues A; Morcillo E; Cortijo J
    Thorax; 2020 Feb; 75(2):132-142. PubMed ID: 31801904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
    Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis.
    Karki S; Surolia R; Hock TD; Guroji P; Zolak JS; Duggal R; Ye T; Thannickal VJ; Antony VB
    FASEB J; 2014 Mar; 28(3):1122-31. PubMed ID: 24265486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.
    Guo J; Fang Y; Jiang F; Li L; Zhou H; Xu X; Ning W
    Eur J Pharmacol; 2019 Dec; 864():172712. PubMed ID: 31586469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study.
    Gan C; Zhang Q; Liu H; Wang G; Wang L; Li Y; Tan Z; Yin W; Yao Y; Xie Y; Ouyang L; Yu L; Ye T
    Respir Res; 2022 Feb; 23(1):32. PubMed ID: 35172837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.